Clinical Trial: Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Better Identification of Latent Tuberculosis Infection Among Israeli Young Adults by Comparison Skin Tests and Interferon Gamma Releasing Assays (IGRA)

Brief Summary: The aim of study is to evaluate the prevalence of latent TB in second generation immigrants from countries with high incidence of tuberculosis (above 20 of 100,000) compare to the control native Israelis without a family member who was born in a country with high incidence of tuberculosis. Using study questionnaire IGRA and tuberculin skin test the investigators expect that the second generation immigrants group will have more positive IGRA test than the control native group.

Detailed Summary:
Sponsor: Sheba Medical Center

Current Primary Outcome: Interferon gamma release assay ( IGRA) [ Time Frame: Up to 3 months after tuberculin skin test ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Sheba Medical Center

Dates:
Date Received: February 25, 2014
Date Started: March 2014
Date Completion: March 2016
Last Updated: February 26, 2014
Last Verified: February 2014